Cargando…
The Total Artificial Heart in End-Stage Congenital Heart Disease
The development of durable ventricular assist devices (VADs) has improved mortality rates and quality of life in patients with end stage heart failure. While the use of VADs has increased dramatically in recent years, there is limited experience with VAD implantation in patients with complex congeni...
Autores principales: | Villa, Chet R., Morales, David L. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422510/ https://www.ncbi.nlm.nih.gov/pubmed/28536530 http://dx.doi.org/10.3389/fphys.2017.00131 |
Ejemplares similares
-
Kidney disease and congenital heart disease: Partnership for life
por: El Sayegh, Skye, et al.
Publicado: (2022) -
Conduction system pacing in pediatric and congenital heart disease
por: Chubb, Henry, et al.
Publicado: (2023) -
Surgical treatment concepts for end-stage congenital heart diseases
por: Delmo Walter, E M, et al.
Publicado: (2013) -
Diaphragm Abnormalities in Patients with End-Stage Heart Failure: NADPH Oxidase Upregulation and Protein Oxidation
por: Ahn, Bumsoo, et al.
Publicado: (2017) -
Mechanical Circulatory Support for End-Stage Heart Failure in Repaired and Palliated Congenital Heart Disease
por: Clark, Joseph B, et al.
Publicado: (2011)